Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of sunitinib consolidation after taxane response in HER2-negative metastatic breast cancer
2005-004587-23Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in breast cancer comparing Sunitinib consolidation with Best supportive care (2 arms). Started Nov 2005; status: completed.
02
Drugs
sunitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-004587-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004587-23.